Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35840029)
Watch
English
Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease.
scientific article published in August 2004
In more languages
default values for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15261607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15261607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
30 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15261607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15261607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
30 December 2019
main subject
pharmacotherapy
0 references
author
Carl E Clarke
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15261607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15261607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
30 December 2019
author name string
Carl E Clarke
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15261607
retrieved
10 August 2017
publication date
1 August 2004
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15261607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15261607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
30 December 2019
published in
Lancet Neurology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15261607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15261607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
30 December 2019
volume
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15261607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15261607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
30 December 2019
issue
8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15261607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15261607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
30 December 2019
page(s)
466-474
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15261607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15261607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
30 December 2019
cites work
Direct economic impact of Parkinson's disease: A research survey in the United Kingdom
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The quality of life in Parkinson's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Health related quality of life in Parkinson's disease: a prospective longitudinal study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Resource use and costs in a Swedish cohort of patients with Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Accuracy of diagnosis in patients with presumed Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Functional brain imaging in the differential diagnosis of Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mortality from Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mortality from Parkinson's disease in England and Wales 1921-89.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Does levodopa therapy delay death in Parkinson's disease? A review of the evidence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A "cure" for Parkinson's disease: can neuroprotection be proven with current trial designs?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of deprenyl on the progression of disability in early Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Living with a person who has Parkinson's disease: the spouse's perspective by stage of disease. Parkinson's Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential i
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of lazabemide on the progression of disability in early Parkinson's disease. The Parkinson Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled trial of lazabemide (Ro 19-6327) in levodopa-treated Parkinson's disease. Parkinson Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Initial agonist treatment of Parkinson disease: a critique
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Slowing Parkinson's disease progression: recent dopamine agonist trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dopamine agonist monotherapy in Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Agonists vs levodopa in PD: the thrilla of whitha
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Abnormalities of the electron transport chain in idiopathic Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aromatic Amino Acids and Modification of Parkinsonism
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic low-dose levodopa therapy in Parkinson's disease: an argument for delaying levodopa therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
When should levodopa be started?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Levodopa: why the controversy?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sustained-release Madopar HBS compared with standard Madopar in the long-term treatment of de novo parkinsonian patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluating drug treatments for Parkinson's disease: how good are the trials?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications: a systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of pulsatile administration of levodopa on dyskinesia induction in drug‐naïve MPTP‐treated common marmosets: Effect of dose, frequency of administration, and brain exposure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monoamine oxidase inhibitors--is it time to up the TEMPO?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rasagiline Mesylate, a New Mao-B Inhibitor for the Treatment of Parkinson's Disease: A Double-Blind Study as Adjunctive Therapy to Levodopa
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subcutaneous apomorphine in the treatment of Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for parkinsonian off-state events
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intranasal apomorphine rescue therapy for parkinsonian "off" periods.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of Neurology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Updated guidelines for the management of Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Continuous transdermal dopaminergic stimulation in advanced Parkinson's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900823-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1474-4422(04)00823-3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15261607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15261607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
30 December 2019
PubMed publication ID
15261607
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15261607
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15261607%20AND%20SRC:MED&resulttype=core&format=json
retrieved
30 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit